FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200467105> ?p ?o ?g. }

• W4200467105 endingPage "26200" @default.
• W4200467105 startingPage "26180" @default.
• W4200467105 abstract "The prognosis of glioma is poor as its pathogenesis and mechanisms underlying cisplatin chemoresistance remain unclear. Nucleosome assembly protein 1 like 1 (NAP1L1) is regarded as a hallmark of malignant tumors. However, the role of NAP1L1 in glioma remains unknown. In this study, we aimed to investigate the molecular functions of NAP1L1 in glioma and its involvement in cisplatin chemoresistance, if any. NAP1L1 was found to be upregulated in samples from The Cancer Genome Atlas (TCGA) database. Immunohistochemistry indicated that NAP1L1 and hepatoma-derived growth factor (HDGF) were enhanced in glioma as compared to the para-tumor tissues. High expressions of NAP1L1 and HDGF were positively correlated with the WHO grade, KPS, Ki-67 index, and recurrence. Moreover, NAP1L1 expression was also positively correlated with the HDGF expression in glioma tissues. Functional studies suggested that knocking down NAP1L1 could significantly inhibit glioma cell proliferation both in vitro and in vivo, as well as enhance the sensitivity of glioma cells to cisplatin (cDDP) in vitro. Mechanistically, NAP1L1 could interact with HDGF at the protein level and they co-localize in the cytoplasm. HDGF knockdown in NAP1L1-overexpressing glioma cells significantly inhibited cell proliferation. Furthermore, HDGF could interact with c-Jun, an oncogenic transcription factor, which eventually induced the expressions of cell cycle promoters, CCND1/CDK4/CDK6. This finding suggested that NAP1L1 could interact with HDGF, and the latter recruited c-Jun, a key oncogenic transcription factor, that further induced CCND1/CDK4/CDK6 expression, thereby promoting proliferation and chemoresistance in glioma cells. High expression of NAP1L1 in glioma tissues indicated shorter overall survival in glioma patients." @default.
• W4200467105 created "2021-12-31" @default.
• W4200467105 creator A5024756156 @default.
• W4200467105 creator A5031056234 @default.
• W4200467105 creator A5055985251 @default.
• W4200467105 creator A5057282740 @default.
• W4200467105 creator A5061457824 @default.
• W4200467105 creator A5061830386 @default.
• W4200467105 creator A5062544897 @default.
• W4200467105 creator A5063141026 @default.
• W4200467105 creator A5065617411 @default.
• W4200467105 creator A5065776128 @default.
• W4200467105 creator A5077248598 @default.
• W4200467105 creator A5077605279 @default.
• W4200467105 creator A5081730905 @default.
• W4200467105 creator A5087648133 @default.
• W4200467105 creator A5088622120 @default.
• W4200467105 date "2021-12-27" @default.
• W4200467105 modified "2023-10-16" @default.
• W4200467105 title "NAP1L1 promotes proliferation and chemoresistance in glioma by inducing CCND1/CDK4/CDK6 expression through its interaction with HDGF and activation of c-Jun" @default.
• W4200467105 cites W1572121278 @default.
• W4200467105 cites W1836915077 @default.
• W4200467105 cites W2021541148 @default.
• W4200467105 cites W2033340092 @default.
• W4200467105 cites W2034549547 @default.
• W4200467105 cites W2039764438 @default.
• W4200467105 cites W2047646614 @default.
• W4200467105 cites W2048257585 @default.
• W4200467105 cites W2051648790 @default.
• W4200467105 cites W2075207798 @default.
• W4200467105 cites W2078510083 @default.
• W4200467105 cites W2131883841 @default.
• W4200467105 cites W2153558039 @default.
• W4200467105 cites W2160237840 @default.
• W4200467105 cites W2165796043 @default.
• W4200467105 cites W2167279371 @default.
• W4200467105 cites W2337353755 @default.
• W4200467105 cites W2414539459 @default.
• W4200467105 cites W2603371662 @default.
• W4200467105 cites W2741838763 @default.
• W4200467105 cites W2789119004 @default.
• W4200467105 cites W2790629586 @default.
• W4200467105 cites W2792171232 @default.
• W4200467105 cites W2886245314 @default.
• W4200467105 cites W2955625357 @default.
• W4200467105 cites W2977538805 @default.
• W4200467105 cites W3005750902 @default.
• W4200467105 cites W3006610479 @default.
• W4200467105 cites W3033636874 @default.
• W4200467105 cites W3048822795 @default.
• W4200467105 cites W3178127564 @default.
• W4200467105 cites W3196158772 @default.
• W4200467105 doi "https://doi.org/10.18632/aging.203805" @default.
• W4200467105 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34959221" @default.
• W4200467105 hasPublicationYear "2021" @default.
• W4200467105 type Work @default.
• W4200467105 citedByCount "14" @default.
• W4200467105 countsByYear W42004671052022 @default.
• W4200467105 countsByYear W42004671052023 @default.
• W4200467105 crossrefType "journal-article" @default.
• W4200467105 hasAuthorship W4200467105A5024756156 @default.
• W4200467105 hasAuthorship W4200467105A5031056234 @default.
• W4200467105 hasAuthorship W4200467105A5055985251 @default.
• W4200467105 hasAuthorship W4200467105A5057282740 @default.
• W4200467105 hasAuthorship W4200467105A5061457824 @default.
• W4200467105 hasAuthorship W4200467105A5061830386 @default.
• W4200467105 hasAuthorship W4200467105A5062544897 @default.
• W4200467105 hasAuthorship W4200467105A5063141026 @default.
• W4200467105 hasAuthorship W4200467105A5065617411 @default.
• W4200467105 hasAuthorship W4200467105A5065776128 @default.
• W4200467105 hasAuthorship W4200467105A5077248598 @default.
• W4200467105 hasAuthorship W4200467105A5077605279 @default.
• W4200467105 hasAuthorship W4200467105A5081730905 @default.
• W4200467105 hasAuthorship W4200467105A5087648133 @default.
• W4200467105 hasAuthorship W4200467105A5088622120 @default.
• W4200467105 hasBestOaLocation W42004671051 @default.
• W4200467105 hasConcept C104317684 @default.
• W4200467105 hasConcept C1491633281 @default.
• W4200467105 hasConcept C173396325 @default.
• W4200467105 hasConcept C185592680 @default.
• W4200467105 hasConcept C199649820 @default.
• W4200467105 hasConcept C199835354 @default.
• W4200467105 hasConcept C2778227246 @default.
• W4200467105 hasConcept C29537977 @default.
• W4200467105 hasConcept C502942594 @default.
• W4200467105 hasConcept C54355233 @default.
• W4200467105 hasConcept C62112901 @default.
• W4200467105 hasConcept C81885089 @default.
• W4200467105 hasConcept C86339819 @default.
• W4200467105 hasConcept C86803240 @default.
• W4200467105 hasConceptScore W4200467105C104317684 @default.
• W4200467105 hasConceptScore W4200467105C1491633281 @default.
• W4200467105 hasConceptScore W4200467105C173396325 @default.
• W4200467105 hasConceptScore W4200467105C185592680 @default.
• W4200467105 hasConceptScore W4200467105C199649820 @default.
• W4200467105 hasConceptScore W4200467105C199835354 @default.
• W4200467105 hasConceptScore W4200467105C2778227246 @default.
• W4200467105 hasConceptScore W4200467105C29537977 @default.

• next